Submission Details
| 510(k) Number | K253092 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 23, 2025 |
| Decision Date | February 13, 2026 |
| Days to Decision | 143 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K253092 is an FDA 510(k) clearance for the Argos Infinity (Rev. 1.0), a Computer, Diagnostic, Pre-programmed, Single-function (Class II — Special Controls, product code DXG), submitted by Retia Medical Systems, Inc. (White Plains, US). The FDA issued a Cleared decision on February 13, 2026, 143 days after receiving the submission on September 23, 2025. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.1435.
| 510(k) Number | K253092 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | September 23, 2025 |
| Decision Date | February 13, 2026 |
| Days to Decision | 143 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DXG — Computer, Diagnostic, Pre-programmed, Single-function |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1435 |